Akebia Therapeutics Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 3.95, this is below the company average, and notable indication of worsening business environment. Average receivable collection period, for the Akebia Therapeutics Inc in Sep 30 2026 quarter, has decreased to 92 days, compared to 96 days, in the Jun 30 2026 quarter.

If we take a look into Healthcare sector 450 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2026 from 2797 to 3078.

What is Receivable Turnover Ratio?
What is Akebia Therapeutics Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

AKBA Receivables Turnover Ratio	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Receivable Change	-44.97 %	-26.51 %	1.62 %	36.85 %	105.85 %
Y / Y Revenue Change	-37.2 %	-21.36 %	-6.61 %	23.93 %	57.01 %
Receivable Turnover Ratio (TTM)	3.95	3.82	3.74	3.82	3.83
AKBA's Total Ranking	# 3078	# 2797	# 1403	# 1360	#
Accounts Receivable average collection period days	92	96	98	96	95
Seq. Receivable Change	-31.9 %	-14.44 %	32.97 %	-28.98 %	-9.05 %
Seq. Revenue Change	-24.88 %	-8.25 %	-7.08 %	-1.95 %	-5.93 %

Receivable Turnover Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 140
Healthcare Sector	# 451
Overall Market	# 3078

Receivable Turnover Ratio Statistics
High	Average	Low
20.64	7.87	3.74
(Dec 31 2017)		(Mar 31 2026)

AKBA Company Profile • Back to AKBA Efficiency Comparisons • Compare AKBA Receivables Turnover Ratio to its Competitors

Financial Statements
Akebia Therapeutics Inc 's Accounts Receivable	$ 36 Millions	Visit AKBA's Balance sheet
Akebia Therapeutics Inc 's Sales TTM	$ 197 Millions	Visit AKBA's Income Statement
Sources of AKBA's Revenues		Visit AKBA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
AKBA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
AKBA's Growth Rates	AKBA's Roa	AKBA's Inventory Turnover Ratio	AKBA's Dividend Comparisons
AKBA's Profitability Ratios	AKBA's Roi	AKBA's Asset Turnover Ratio	AKBA's Dividend Growth
AKBA's Valuation Ratios	AKBA's Roe	AKBA's Financial Strength Ratios	AKBA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Sep 30 2026	Receivable at quarter ending Sep 30 2026
Corcept Therapeutics Inc	13.44	$ 963.647 Millions	$ 71.710 Millions
Chemed Corporation	12.65	$ 2,661.041 Millions	$ 210.387 Millions
Caredx Inc	11.75	$ 497.396 Millions	$ 42.330 Millions
Teladoc Health Inc	11.50	$ 2,468.143 Millions	$ 214.604 Millions
Biodesix Inc	11.45	$ 105.212 Millions	$ 9.192 Millions
Icu Medical Inc	11.32	$ 2,183.556 Millions	$ 192.845 Millions
Mannkind Corporation	10.97	$ 413.370 Millions	$ 37.686 Millions
Iqvia Holdings Inc	10.43	$ 17,311.000 Millions	$ 1,659.500 Millions
Voyager Therapeutics Inc	9.84	$ 25.108 Millions	$ 2.551 Millions
Encompass Health Corporation	9.41	$ 6,338.100 Millions	$ 673.625 Millions
Bausch Health Companies Inc	9.15	$ 11,113.000 Millions	$ 1,215.000 Millions
Pacs Group Inc	8.88	$ 5,705.049 Millions	$ 642.729 Millions
Lexicon Pharmaceuticals Inc	8.77	$ 38.537 Millions	$ 4.396 Millions
Axogen inc	8.71	$ 266.926 Millions	$ 30.654 Millions
Avita Medical Inc	8.65	$ 84.683 Millions	$ 9.795 Millions
Ensign Group Inc	8.62	$ 5,674.305 Millions	$ 658.477 Millions
Pediatrix Medical Group Inc	8.57	$ 1,959.124 Millions	$ 228.471 Millions
Tenet Healthcare Corp	8.54	$ 22,154.000 Millions	$ 2,593.250 Millions
Brightspring Health Services Inc	8.50	$ 9,479.144 Millions	$ 1,114.763 Millions
Sotera Health Company	8.49	$ 1,230.250 Millions	$ 144.974 Millions
Acadia Pharmaceuticals Inc	8.46	$ 1,202.301 Millions	$ 142.117 Millions
Novavax inc	8.33	$ 411.649 Millions	$ 49.414 Millions
Tactile Systems Technology Inc	8.23	$ 357.176 Millions	$ 43.385 Millions
Penumbra Inc	8.22	$ 1,560.334 Millions	$ 189.735 Millions
Inspire Medical Systems inc	8.15	$ 882.194 Millions	$ 108.207 Millions
Adapthealth Corp	8.14	$ 3,152.043 Millions	$ 387.280 Millions
Rhythm Pharmaceuticals Inc	8.03	$ 280.748 Millions	$ 34.950 Millions
Alphatec Holdings Inc	7.91	$ 839.652 Millions	$ 106.153 Millions
Exelixis Inc	7.89	$ 2,496.861 Millions	$ 316.636 Millions
Henry Schein Inc	7.84	$ 13,734.000 Millions	$ 1,752.000 Millions

Date modified: 2026-11-06T12:59:24+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.